HTC
IDXX icon

Haverford Trust Company’s Idexx Laboratories IDXX Stock Holding History

Haverford Trust Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-341
Closed -$231K – 427
2025
Q4 		$231K Buy
341
+3
+0.9% +$2.04K ﹤0.01% 388
2025
Q3 		$216K Sell
338
-56
-14% -$34K ﹤0.01% 384
2025
Q2 		$211K Buy
+394
New +$188K ﹤0.01% 389
2024
Q4 		– Sell
-545
Closed -$275K – 394
2024
Q3 		$275K Buy
545
+77
+16% +$37.4K ﹤0.01% 369
2024
Q2 		$228K Buy
468
+84
+22% +$42.2K ﹤0.01% 382
2024
Q1 		$207K Hold
384
– – ﹤0.01% 369
2023
Q4 		$213K Buy
+384
New +$180K ﹤0.01% 351

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Haverford Trust Company's IDXX Position: Q1 2026 in Review

Haverford Trust Company sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 341 shares — an estimated $231K sold.

Haverford Trust Company first reported a position in IDXX in Q4 2023 and held it in 7 quarters. The position peaked at $275K in Q3 2024. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Haverford Trust Company reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Haverford Trust Company sold 341 Idexx Laboratories shares in Q1 2026, an estimated $231K.
  • Haverford Trust Company first reported a position in Idexx Laboratories in Q4 2023 and held it in 7 quarters.
  • Haverford Trust Company's Idexx Laboratories position peaked at $275K in Q3 2024.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Haverford Trust Company's 13F filing for Q1 2026, filed 11 May 2026.